RAF1 and non-small cell lung carcinoma: Overexpression of p70S6K following Raf‐1 knock‐down resulted in significantly more NSCLC cells entering the cell cycle and progressing into S/G2‐M phases than that observed with Raf‐1 ablation (Figure 4, shRaf‐1 + OE‐p70S6K vs shRaf‐1).